🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Evolus, Inc.

EOLS Healthcare
$7.99 +$0.08 (1.01%)
Market Cap: $527.74 M
Gurus Holding
4
Popularity Rank
#2614
% of Shares Held
2.94%
Net Activity (Q2 2026)
+$10.93 M

Guru Ownership Trend

Guru Analysis for Evolus, Inc. (EOLS)

Evolus, Inc. (EOLS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.5 M.

Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $10.93 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 280.0%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 10.8%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$11.19 M
Total Buy Value
New Buys 2
Additions 1
-$253,004.66
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Evolus, Inc. (EOLS)

Major holders include Steven Cohen ($10.47 M), Renaissance Technologies (RenTech) ($2.1 M), Cliff Asness ($677,087). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.94 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10.93 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited EOLS. The total reported sell value was $253,004.66.

Yes, 2 managers opened new positions in EOLS, and 1 increased their existing holdings. The total reported buy value was $11.19 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 1,508,518 $10.47 M Q2 2026
0.00% Reduce -10.8% 302,569 $2.1 M Q2 2026
0.00% Add 280.0% 97,563 $677,087 Q2 2026
0.00% New Buy 31,547 $218,936 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form